# Glenmark Pharmaceuticals Limited – FDA Inspection, May 29, 2015

Source: https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/e5a82147-ec6f-492c-83d4-281cf15f8b12
Source feed: FDA_Inspections

> FDA inspection 929619 of Glenmark Pharmaceuticals Limited, May 29, 2015. Classification: Voluntary Action Indicated (VAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 929619
- Company Name: Glenmark Pharmaceuticals Limited
- Inspection Date: 2015-05-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1172425 - 2022-06-22](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/84dfdb76-1ec3-4ae9-a550-4882585f55ac)
- [FDA Inspection 1087639 - 2019-04-20](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/3d480abd-bd12-4e91-b835-c48415d17346)
- FDA Inspection 1070594 - 2018-09-21
- [FDA Inspection 1031652 - 2017-11-11](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/9dbf23a8-439d-4a57-bd29-3319b9215d79)
- FDA Inspection 1012923 - 2017-04-19

Company: https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/66c964bb-f670-493b-ab86-aa8507e68a5d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
